Silverarc-Capital-Management

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-14
Total Holdings
69
Total Value
488995340
Accession Number
0001420506-25-001107
Form Type
13F-HR
Manager Name
Silverarc-Capital-Management
Data Enrichment
87% identified
60 identified9 unidentified

Holdings

69 positions • $489.0M total value
Manager:
Search and click to pin securities to the top
Page 3 of 4
Blueprint Medicines Corp
Shares:37.3K
Value:$3.3M
% of Portfolio:0.7% ($3.3M/$489.0M)
Structure Therapeutics Inc.
Shares:188.1K
Value:$3.3M
% of Portfolio:0.7% ($3.3M/$489.0M)
Benitec Biopharma Inc.
Shares:250.0K
Value:$3.3M
% of Portfolio:0.7% ($3.3M/$489.0M)
Liquidia Corp
Shares:214.1K
Value:$3.2M
% of Portfolio:0.6% ($3.2M/$489.0M)
PTC THERAPEUTICS, INC.
Shares:60.4K
Value:$3.1M
% of Portfolio:0.6% ($3.1M/$489.0M)
59267L107
Shares:112.8K
Value:$3.1M
% of Portfolio:0.6% ($3.1M/$489.0M)
834203959
Shares:42.5K
Value:$3.0M
% of Portfolio:0.6% ($3.0M/$489.0M)
BIODESIX INC
Shares:4.1M
Value:$2.6M
% of Portfolio:0.5% ($2.6M/$489.0M)
DELCATH SYSTEMS, INC.
Shares:191.5K
Value:$2.4M
% of Portfolio:0.5% ($2.4M/$489.0M)
uniQure N.V.
Shares:203.4K
Value:$2.2M
% of Portfolio:0.4% ($2.2M/$489.0M)
Kiniksa Pharmaceuticals International, plc
Shares:88.2K
Value:$2.0M
% of Portfolio:0.4% ($2.0M/$489.0M)
Solid Biosciences Inc.
Shares:452.2K
Value:$1.7M
% of Portfolio:0.3% ($1.7M/$489.0M)
Compass Therapeutics, Inc.
Shares:874.9K
Value:$1.7M
% of Portfolio:0.3% ($1.7M/$489.0M)
C4 Therapeutics, Inc.
Shares:882.3K
Value:$1.4M
% of Portfolio:0.3% ($1.4M/$489.0M)
KALA BIO, Inc.
Shares:246.1K
Value:$1.4M
% of Portfolio:0.3% ($1.4M/$489.0M)
Unicycive Therapeutics, Inc.
Shares:2.4M
Value:$1.4M
% of Portfolio:0.3% ($1.4M/$489.0M)
Abivax S.A.
Shares:210.9K
Value:$1.3M
% of Portfolio:0.3% ($1.3M/$489.0M)
Kodiak Sciences Inc.
Shares:441.8K
Value:$1.2M
% of Portfolio:0.3% ($1.2M/$489.0M)
829401108
Shares:114.1K
Value:$1.2M
% of Portfolio:0.2% ($1.2M/$489.0M)
InflaRx N.V.
Shares:1.2M
Value:$1.2M
% of Portfolio:0.2% ($1.2M/$489.0M)